| Product Name | Apricitabine - API |
| Product Code | DA-A282-01 |
| Chemical name | Apricitabine |
| Synonyms | 4-Amino-1-((2R,4R)-2-(hydroxymethyl)-1,3-oxathiolan-4-yl)pyrimidin-2(1H)-one; 2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-4-yl]-, (2R-cis)-; 4-Amino-1-[(2R,4R)-2-(hydroxymethyl)-1,3-oxathiolan-4-yl]-2(1H)-pyrimidinone; (-)-2′-Deoxy-3′-oxa-4′-thiocytidine; |
| Impurity | NA |
| CAS Number | 160707-69-7 |
| Alternate CAS # | NA |
| Molecular form | C8H11N3O3S |
| Appearance | NA |
| Melting Point | NA |
| Mol. Weight | 229.25 |
| Storage | 2-8°C Refrigerator |
| Solubility | NA |
| Stability | NA |
| Category | impurities,metabolites,pharmaceutical standards,intermediates,Fine Chemicals |
| Boiling Point | NA |
| Applications | Apricitabine has been used in trials studying the treatment of HIV Infections. Apricitabine is a type of medicine called a nucleoside reverse transcriptase inhibitor (NRTI). NRTIs work by blocking reverse transcriptase, a protein that HIV needs to make more copies of itself. |
| Dangerous Goods Info | NA |
| References | NA |
| Extra Notes | NA |
| Documents (MSDS) | No Data Available |
| Keywords | NA |
